Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW597599B vs Paroxetine in Major Depressive Disorder
NCT00048204Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2002
- Primary completion
- Sep 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of vestipitant in major depressive disorder (MDD), sponsored by GSK. Started Nov 2002; status: completed.
02
Drugs
vestipitant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00048204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048204.